Isoescin IB
CAS: 219944-46-4
Ref. 3D-FI145247
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
- (3β,16α,21β,22α)-28-Acetoxy-16,22,24-trihydroxy-21-{[(2Z)-2-methylbut-2-enoyl]oxy}olean-12-en-3-yl β-D-glucopyranosyl-(1->2)-[β-D-glucopyranosyl-(1-> 4)]-β-D-glucopyranosiduronic acid
- 2-butenoic acid, 2-methyl-, (3β,16α,21β,22α)-28-(acetyloxy)-3-[[O-β-D-glucopyranosyl-(1-> 2)-O-[β-D-glucopyranosyl-(1->4)]-β-D-glucopyranuronosyl]oxy]-16,22,24-trihydroxyolean-12-en-21-yl ester, (2Z)-
- (3β,16α,21β,22α)-28-(acetyloxy)-16,22,24-trihydroxy-21-{[(2Z)-2-methylbut-2-enoyl]oxy}olean-12-en-3-yl β-D-glucopyranosyl-(1->2)-[β-D-glucopyranosyl-(1->4)]-β-D-glucopyranosiduronic acid
- Aescin D
Isoescin IB is a saponin that has been shown to have an inhibitory effect on the growth of bacteria, yeast and fungi. Isoescin IB also has been found to have pharmacokinetic properties that make it suitable as a drug candidate for clinical use. The study of the pharmacokinetics of Isoescin IB was carried out in rats, with a sample preparation technique involving quillaja saponaria (QS) and aesculus hippocastanum (AH). Its toxicity studies were conducted using a Sprague-Dawley rat model. Isoescin IB is not currently available as a pharmaceutical dosage form.
Chemical properties
Technical inquiry about: 3D-FI145247 Isoescin IB
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
